P
Pablo G. Sanchez
Researcher at University of Pittsburgh
Publications - 199
Citations - 3268
Pablo G. Sanchez is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Lung transplantation & Medicine. The author has an hindex of 26, co-authored 140 publications receiving 2480 citations. Previous affiliations of Pablo G. Sanchez include University of Navarra & Universidade Federal do Rio Grande do Sul.
Papers
More filters
Journal ArticleDOI
Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease
John E. McDonough,Ren Yuan,Masaru Suzuki,Nazgol Seyednejad,W. Mark Elliott,Pablo G. Sanchez,Alexander C. Wright,Warren B. Gefter,Leslie A. Litzky,Harvey O. Coxson,Peter D. Paré,Don D. Sin,Richard A. Pierce,Jason C. Woods,Annette McWilliams,John R. Mayo,Stephen Lam,Joel D. Cooper,James C. Hogg +18 more
TL;DR: Results show that narrowing and disappearance of small conducting airways before the onset of emphysematous destruction can explain the increased peripheral airway resistance reported in COPD.
Journal ArticleDOI
Sustainability in the boardroom: An empirical examination of Dow Jones Sustainability World Index leaders
TL;DR: In this article, an analysis is performed of the governance systems of the 18 corporations that are leading the market sectors considered by the Dow Jones Sustainability World Index (DWSVI), and the sustainable corporate governance model that emerges from that analysis is proposed.
Posted Content
Sustainability in the boardroom: An empirical examination of Dow Jones sustainability world index leaders
TL;DR: In this paper, the authors examine how corporate governance systems are evolving in order to integrate sustainable development thinking into them and propose the sustainable corporate governance model that emerges from that analysis, based on the results of their in depth analysis of the 18 cases.
Journal ArticleDOI
Ex-vivo lung perfusion.
Pablo G. Sanchez,Frank D'Ovidio +1 more
TL;DR: Ex-vivo lung perfusion has already proved its value as a tool to identify ’good’ lungs from the previously rejected pool, but as new therapeutics arise, EVLP will also prove itsvalue as a reproducible platform for their evaluation.
Journal ArticleDOI
Different Paths to Collaboration Between Businesses and Civil Society and the Role of Third Parties
TL;DR: In this article, the authors suggest that one of the unexplored paths toward collaboration between firms and civil society organizations starts with confrontation or potential conflict, and that the transition toward collaboration can be further understood if one focuses on triadic relationships rather than dyadic ones.